PharmiWeb

YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency (AATD)

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced ...
Orlando Sentinel

Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

WASHINGTON (AP) — Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol. It’s very early stage research, ...
NPR

CRISPR gene-editing works to reduce high cholesterol in a new study

A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday. The study, which ...
Forbes

New Era For Gene Editing: Tech Corrects Complex DNA

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
C&EN

Inflection Point: The era-spanning epiphanies that enabled gene editing

C&EN’s award-winning podcast Inflection Point leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three ...